Chemomab Therapeutics Ltd. (CMMB) stock
CMMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.64+0.02 (+1.23%)
Close on Nov 17, 2026Market cap $11.80MP/E 1.1Yield –
Chemomab Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Chemomab Therapeutics's operating cash flow for the twelve months ending Jun 30, 2023 was -$25.63M. For fiscal 2025 it was -$11.13M. The highest annual figure on record is -$3.73M in fiscal 2016.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$11.13M | – |
| FY2024 | Dec 31, 2024 | -$15.39M | – |
| FY2023 | Dec 31, 2023 | -$23.61M | – |
| FY2022 | Dec 31, 2022 | -$20.37M | – |
| FY2021 | Dec 31, 2021 | -$12.37M | – |
| FY2020 | Dec 31, 2020 | -$5.24M | – |
| FY2019 | Dec 31, 2019 | -$16.46M | – |
| FY2018 | Dec 31, 2018 | -$14.22M | – |
| FY2017 | Dec 31, 2017 | -$8.52M | – |
| FY2016 | Dec 31, 2016 | -$3.73M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2023 | Jun 30, 2023 | -$7.49M | – |
| Q1 FY2023 | Mar 31, 2023 | -$7.19M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.70M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.26M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.70M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.71M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.89M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.58M | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.61M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.29M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.56M | – |
| Q3 FY2020 | Sep 30, 2020 | -$901.00K | – |
| Q2 FY2020 | Jun 30, 2020 | -$873.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.91M | – |
| Q4 FY2019 | Dec 31, 2019 | -$5.91M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.51M | – |
| Q2 FY2019 | Jun 30, 2019 | -$3.92M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.12M | – |
See a number that looks wrong?